In several solid malignancies, including pancreatic cancer [38], breast cancer [39], colorectal cancer [40], and head and neck squamous cell carcinoma [41], BGN has been reported to promote tumor cell phenotypes, such as proliferation, migration, and immune suppression, thereby contributing to tumor progression. The gene discussed is BGN; the disease is breast carcinoma.